Regenerative Medical Technology (RMTG) Revenue (2018 - 2026)
Regenerative Medical Technology (RMTG) posted quarterly Revenue of $2.6 million for Q1 2026, up 93.45% year-over-year from $1.4 million in Q1 2025, and up 67.91% quarter-over-quarter from $1.6 million in Q4 2025.
Regenerative Medical Technology (RMTG) Revenue (2018 - 2026) Analysis & Trends
Regenerative Medical Technology's Revenue history runs 9 years deep, the most recent figure standing at $2.6 million for Q1 2026.
- In Q1 2026, Revenue rose 93.45% year-over-year to $2.6 million; the TTM figure through Mar 2026 stood at $6.4 million (up 36.96% YoY), while the FY2025 annual figure was $5.1 million, up 24.17% from the prior year.
- Revenue for Q1 2026 stood at $2.6 million, up from $1.6 million in the prior quarter.
- The five-year high for Revenue was $2.6 million in Q1 2026, with the low at $297522.0 in Q2 2022.
- The 5-year median for Revenue is $793329.0 (2024), against an average of $928666.9.
- The sharpest annual moves came in 2022 and 2024: Revenue soared 6624.02% in 2022, then climbed 3.92% in 2024.
- Regenerative Medical Technology's Revenue stood at $566256.0 in 2022, then advanced by 8.71% to $615568.0 in 2023, then jumped by 145.44% to $1.5 million in 2024, then increased by 4.04% to $1.6 million in 2025, then surged by 67.91% to $2.6 million in 2026.
- Business Quant data shows RMTG's Revenue at $2.6 million in Q1 2026, $1.6 million in Q4 2025, and $1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | Regenerative Medical Technology | 961,772.49 | -99,675.51 | 1.77 Mn | 2.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.64 Mn |
| Dec 31, 2025 | 1.57 Mn |
| Sep 30, 2025 | 1.18 Mn |
| Jun 30, 2025 | 983,518.00 |
| Mar 31, 2025 | 1.36 Mn |
| Dec 31, 2024 | 1.51 Mn |
| Sep 30, 2024 | 986,308.00 |
| Jun 30, 2024 | 793,329.00 |
| Mar 31, 2024 | 817,034.00 |
| Dec 31, 2023 | 615,568.00 |
| Sep 30, 2023 | 646,828.00 |
| Jun 30, 2023 | 361,359.00 |
| Mar 31, 2023 | 786,198.00 |
| Dec 31, 2022 | 566,256.00 |
| Sep 30, 2022 | 367,697.00 |
| Jun 30, 2022 | 297,522.00 |
| Mar 31, 2022 | 298,748.00 |
| Dec 31, 2021 | 252,633.00 |
| Sep 30, 2021 | 165,042.00 |
| Jun 30, 2021 | 15,769.00 |